Collectively, these results demonstrate that SMARCD3-BAF, in concert with FOXA1, is an important regulator of fatty acid metabolism, and draws a link between SWI/SNF and stem cell-enriched metabolic programs in pancreatic cancer. Here, FOXA1 is linked to pancreatic neoplasm.